FDA No Longer Supports Compounded Pergolide Production

The U.S. FDA will no longer support the production of compounded pergolide for use in horses. The change comes several months after the FDA approved a pergolide mesylate tablet for the treatment of clinical signs associated with PPID in horses.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners